Repare Therapeutics (RPTX) Reiterated Overweight at Piper Sandler Ahead of Phase I Data
Tweet Send to a Friend
Piper Sandler analyst Joseph Catanzaro reiterated an Overweight rating and $40.00 price target on Repare Therapeutics (NASDAQ: RPTX) ahead of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
